Bank of America’s Quoin Pharmaceuticals QNRX Stock Holding History

Bank of America’s Portfolio QNRX Stock Details QNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-29	Closed	-$580	–	8360
2024 Q2	$580	Buy	+29	New	+$737	﹤0.01%	7332
2022 Q1	–	Hold	0	–	-$4K	–	8663
2021 Q4	–	Hold	0	–	–	–	7887
2018 Q2	–	Hold	0	–	–	–	7277
2018 Q1	–	Hold	0	–	–	–	7297

Other funds holding QNRX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bank of America's QNRX Position: Q3 2024 in Review

Bank of America sold out of Quoin Pharmaceuticals (QNRX) in Q3 2024, closing a stake of 29 shares — an estimated $580 sold.

Bank of America first reported a position in QNRX in Q2 2024 and held it in 1 quarter. The position peaked at $580 in Q2 2024. 7 funds tracked by Wall St. Rank hold QNRX as of Q3 2024.

Bank of America reported no remaining Quoin Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
Bank of America sold 29 Quoin Pharmaceuticals shares in Q3 2024, an estimated $580.
Bank of America first reported a position in Quoin Pharmaceuticals in Q2 2024 and held it in 1 quarter.
Bank of America's Quoin Pharmaceuticals position peaked at $580 in Q2 2024.
7 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q3 2024.

Based on Bank of America's 13F filing for Q3 2024, filed 14 Nov 2024.